Biopharmaceutical company Incyte plans to expand its headquarters operations in Wilmington, Delaware. The project is expected to create up to 500 jobs over the coming years.
Incyte today announced the expansion of its presence in Delaware with the acquisition of two buildings at 1100 North King Street and 1100 North French Street in downtown Wilmington. This acquisition.
Incyte will buy two former MBNA buildings in downtown Wilmington, Bracebridge I and Bracebridge III, which will allow the biopharmaceutical company to move
Wilmington City Council passes resolution to clearing the way for dam removal on the Brandywine delawarepublic.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from delawarepublic.org Daily Mail and Mail on Sunday newspapers.